Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Change in Account Payables came in at $275000.0 in Q3 2025, up 587.5% year-on-year from $40000.0 in Q3 2024, and up 170.15% on a QoQ basis from -$392000.0 in Q2 2025.
Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Change in Account Payables data on file, last reported at $275000.0 in Q3 2025.
- On a quarterly basis, Change in Account Payables rose 587.5% year-over-year to $275000.0 in Q3 2025; TTM through Sep 2025 was -$495000.0, a 266.67% decrease from a year earlier, with the FY2024 full-year figure at -$96000.0, up 79.7% from the prior year.
- Change in Account Payables for Q3 2025 stood at $275000.0, up from -$392000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for RBOT reached as high as $3.7 million in Q3 2022 and fell as low as -$3.3 million in Q4 2022.
- Historically, Change in Account Payables has averaged $22684.2 across 5 years, with a median of $14000.0 in 2024.
- Across the five-year window, Change in Account Payables surged 6748.41% in 2021 and sank 1135.71% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $937000.0 in 2021, then slumped by 447.71% to -$3.3 million in 2022, then soared by 91.65% to -$272000.0 in 2023, then grew by 14.34% to -$233000.0 in 2024, then surged by 218.03% to $275000.0 in 2025.
- Per Business Quant data, the three most recent Change in Account Payables figures were $275000.0 in Q3 2025, -$392000.0 in Q2 2025, and -$145000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 275,000.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Jun 30, 2023 | -351,000.00 |